Prominent Physician/Researchers to Present Case for Ivermectin to U.S. Senate Committee on Homeland Security & Governmental Affairs

Prominent Physician/Researchers to Present Case for Ivermectin to U.S. Senate Committee on Homeland Security & Governmental Affairs

The U.S. Senate Committee on Homeland Security & Governmental Affairs will hold a full committee hearing on December 8, 2020, at 10:00 AM at the Senate Dirksen Building and via video conference. Titled “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II,” invited witnesses to include Jane M. Orient, MD, Executive Director Association of American Physicians and Surgeons, Pierre Kory, MD, Associate Professor of Medicine, St. Luke’s Aurora Medical Center, Jean-Jacques Rajter, MD, Pulmonologist, Broward Health Medical Center and ICON study co-author and Ramin Oskoui, MD, Vice President of Medical Staff, Sibley Memorial Hospital and Chief Executive Officer of Foxhall Cardiology. Prominent among discussion topics will be the use of ivermectin as a treatment for early-stage, mild to moderate COVID-19 cases. To date, although well over $12 billion U.S. dollars have been spent by the taxpayers, there has been no breakthrough for early-stage treatment, an incredibly important period to get COVID-19 under control. There is evidence that some generic-based treatments can help accomplish this objective. Plan to watch this event to learn more.

Two of the presenters have been guests on the TrialSite News Podcast show including Dr. Pierre Kory and Dr. Jean-Jacques Rajter, along with his physician/research spouse Dr. Juliana Cepelowicz.

The ICON Study Findings will be Discussed

Among other things, Dr. Rajter will discuss the critical importance of low cost, widely available generic treatments such as ivermectin and the promise to help close the treatment gap for those patients diagnosed with early-stage, mild to moderate COVID-19. Dr. Rajter led the important study in the U.S. known as the ICON study, the results of which were published in the peer-reviewed journal Chest

Front Line COVID-19 Critical Care Alliance

Dr. Pierre Kory is a founding member of the Front Line COVID-19 Critical Care Alliance (FLCCC) targeting prophylaxis and treatment protocols for COVID-19.

What have we Learned?

Dr. Jane Orient is the Executive Director of the Association of American Physicians and Surgeons recently authored an article called “Lessons from the 9-Month COVID ‘Emergency’: What Have you Learned?” A liberty-inspired individual, Dr. Orient believes Americans should understand the danger involved in handing all authority (and trust) to government-anointed experts of the medical-industrial-regulatory complex.

Call to Action: Follow the link to track how to access this event this coming Tuesday, December 8, at 10:00 AM ET.


  1. Why did you not approve my comment why the FLCCC did not want Dr Fauci in the meeting before Senator Johnson committee on Dec. 8 on urging early outpatient treatment of Covid19 victims using Ivermectin. Has Trial Site news decided to remove all negative but accurate comments regarding Dr. Fauci including his illogical support of Remdesivir and his negative comments about hydroxychlorquine even as Dr Brian has treated over 2,000 high risk Covid-19 outpatients with no deaths. Dr Paul Marik and many other doctors have reportedRemdesivir does not provide a mortality benefit and yet Dr Fauci supported Remdesivir. Is Trial Site News afraid to let its readers respond to another reader’s question why Dr Fauci was not invited to the Ivermectin meeting when many informed readers know Fauci will try to stop use of Ivermectin ?

  2. I talked to a person with the CDC back in April about Ivermectin being used on Covid-19 patients in Florida, and in the Orient. Was it not researched at that time by a committee?

  3. I sincerely hope that saneness will prevail here and Hydroxychloroquine and Ivermectin get their day in court and other governments other than the USA take heed and act positively and quickly to stop the carnage

  4. Yes, Americans should understand the danger involved in handing all authority (and trust) to government-anointed experts of the medical-industrial-regulatory complex when those entities are all after money, not truth.

  5. Why am I (an MD) not reading anything here about the FDA’s mishandling of the very promising results of Leronlimab? The impressive Phase ll results of this CCR5 blocker, when used early for mild to moderate COVID cases, have been ignored. Sadly, the answer may be as simple as “follow the money.”

  6. This is excellent news! Early Outpatient treatment must be aggressively pursued immediately to reduce the catastrophic death toll that is sharply rising. There are a large number of repurposed therapeutics, vitamins and supplements that shown very promising early results in pilot RCTs in Covid-19. These decisions to treat outpatients should be left to the judgement of the expertise of physicians and their patients. The NIH Treatment Guidelines recommending against off label treatments ties the hands of a very large percentage of US doctors who are under contract to follow their Guidelines. The NIH Guidelines are grossly out of date. They ignore a large and compelling body of International evidence from RCTs, Observational trials, and case series. They also falsely state that the ICON Trial has not been peer reviewed. It was peer reviewed and published in a prestigious international journal back in October. Hopefully, citizens will continue to write their representatives to demand the NIH update their guidelines and allow physicians to treat their patients.

    1. Good point…he tends to be a relatively conservative medical comunity voice that could moderaate any hyperbole. On the other hand, he might be viewed as an obstacle.

      I agree that it is time to get this alternative treatment a fair hearing,,,but I question whether the Homeland Security and Government Affairs Committee is the right forum. Ron Johnson (R-WI) chairs this committee and he has invited Dr. Kory in the past, so I think that is the connection.

    2. They have already made their minds up taking a negative approach regardles of the psitive evidence presented I draw your attention to the first round where an opposing “professional” called three highly qualified professionals Snake Oil doctors and when asked if he had ever treated a Corona Virus patient he had to admit he hadn’t That is what these honest hard working doctors are up against

    3. Juan,
      We all must pause and consider any and all connections to the medical-industrial-regulatory complex. Institutional paradigm shift is a behemoth. Sadly, complacent minds have not shifted in the face of this pandemic.

      Dr. Orient believes Americans should understand the danger involved in handing all authority (and trust) to government-anointed experts of the medical-industrial-regulatory complex.

    4. Because Dr Fauci has consistently without credible data
      trashed early treatment of Hydroxychlorquine (HCQ) despite many highly successful Covid-19 treatments by Medical Doctors around the world including over 2,000 consecutive high risk outpatient treatments by Dr Brian Tyson in El Centro, with no deaths and only one hospitalization. Dr. Vladmir Zelenko similarly treated 400 high risk outpatients with his famous cocktail of HCQ + Azithromycin + Zinc Sulfate with only two deaths. Dr. Ban C. Truong using the same 3 drug cocktail plus Vitamin D and C supplements successfully treated 69 of 72 high risk outpatients including 18 from a little Russian Church in Battleground WA and I could mention the over 300 over 100 outpatients treated by Dr. Fareed and Dr. Peter McCullough respectively.

      Dr. Fauci also irrationally supported the Emergency Use of Gilead’s highly expensive Remdesivir drug despite several studies that showed Remdesivir did not provide any mortality benefit compared to placebo, which scaleup cost USA taxpayers billions of dollars to scale up for widespread use of a drug that did not even have a RCT study that supported the use of Remdesivir.

      Dr Harvey Risch and others have stated that the failure to scale up the three drug HCQ cocktail caused the deaths of over 100,000 USA Covid-19 victims. No single person is more responsible for stopping the FDA’s approval of a Emergency Use Authorization for early treatment of Covid-19 outpatients with HCQ treatment than Dr. Fauci. 0

      Do we need any more reasons not to invite Dr. Fauci to a meeting that is seeking governmental approval of a low cost, widely available, low risk Ivermectin drug which MANY documents at FLCC.NET establishes that Ivermectin has both anti-viral and anti-inflammatory properties and is effective in treating Covid-19 both in the Symptomatic viral replication phase of the Covid-19 disease and the pulmonary phases of the disease. And many published, but not peer reviewed studies show that Ivermectin is an effective prophylaxis and a very effective therapeutic treatment of Covid-19 infected outpatients and provides mortality benefits for hospitalized patients.

      It is obvious the poor countries in this world cannot afford expensive designer drugs like Remdesivir and others that costs several thousands of dollars. It is unfortunate that large Pharma companies and USA’s government agencies have not established an agency whose objective is to select and scale up only low cost, low risk, widely available and promising drug cocktails like Hydroxychlorquine and Ivermectin. Instead of the USA spending billions of dollars to scale up expensive designer drugs promoted by big Pharma companies, the NIH, the CDC, and the FDA, why not create a USA agency that spends billions of dollars to scale up and evaluate every low cost, low risk, widely available drug suggested by successful practicing medical doctors instead of government bureaucrats.

      Hopefully all contributing participants will support the scale up of this promising Ivermectin drug, and other promising drugs like HCQ.